News & Opinion

Covering the life sciences inside and out

Peer review varies in quality and thoroughness. Making it publicly available could improve it.

A recent toast to James Watson highlights a tolerance for bigotry many want excised from the scientific community.

Moderate ultraviolet light exposure boosts the brainpower of mice thanks to increased production of the neurotransmitter glutamate.  

Researchers find a link between molecules released by commensal bacteria and the degree of inflammation in a mouse model of MS.

The Nutshell

Daily News Roundup

Early exposure to common microbes could stop leukemia from manifesting in children.

The University College London researcher investigated how environmental pressures affect animals.

The Chinese giant salamander is not one but five different species.

Fall served in the White House Office of Science and Technology Policy under President Barack Obama.

Current Issue

May 2018

Issue Cover: Rare Diseases

When the O’Neills learned that their daughter had Sanfilippo syndrome, a devastating rare disease, they created a GoFundMe campaign that raised $2 million in less than a year.

Clinical analyses of patients’ gene sequences are helping to provide answers where none were available before.

Crowdfunding can power investigations into diseases that would otherwise receive little attention.

Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.

Multimedia

Video, Slideshows, Infographics

Ali Guthy, the daughter of cosmetics entrepreneur Victoria Jackson, discusses NMO, the rare autoimmune disease she suffers from.

Watch the viral video that helped the family of a child with Sanfilippo syndrome raise more than $2 million.

The Marketplace

Sponsored Product Updates

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the release of a range of anti-vedolizumab antibodies.

Bio-Rad Laboratories Inc. (NYSE: BIO and BIOb) today announced the launch of StarBright Blue 520 Fluorescent Secondary Antibodies, fluorescent dye–labeled secondary antibodies for use in multiplex western blotting.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony™ S6 cell sorter, which will be on display at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague.

SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), today announced the introduction of 2view™, a unique detection method optimised for Western blotting, under its Expedeon brand name.  

Learn about common challenges to protein preparation protocols, typical protein isolation workflows, considerations when working with challenging samples, and how to confirm intact protein extraction with this eBook!

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of the Bio-Plex Pro Human Cytokine Screening Panel, the first validated high-performance multiplex assay on the market. The panel can identify and quantify 48 different analytes linked to heart disease, autoimmunity and allergy, cancer, and many other conditions.

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. RNA Moves a Memory From One Snail to Another
  3. Could a Dose of Sunshine Make You Smarter?
  4. Sweden Cancels Agreement With Elsevier Over Open Access

Featured Comment

I remember watching GATTACA with some other grad students in the 90's, we liked it but laughed at the 'impossible' fast sequencing done to validate people's identities. Now we do seven impossible things before breakfast, so to speak.

Allison Mackay, commenting on The Scientist's story about a new, hand-held sequencer that can reportedly decode the entire human genome.

Pocket-Size Nanopore Device Sequences Entire Human Genome